GENEREX BIOTECHNOLOGY CORP Purchase Agreements
17 Contracts & Agreements
- Securities Purchase Agreement dated as of August 4, 2020 between the Company and each buyer a signatory thereto (Filed With SEC on August 7, 2020)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 18, 2020)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 22, 2019)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 15, 2019)
- CONFIDENTIALAMENDMENT TO SECURITIES PURCHASE AGREEMENT THISAMENDMENT (this “Amendment”) is made as of this day of June, 2018 by and between: GENEREXBIOTECHNOLOGY CORPORATION... (Filed With SEC on July 9, 2018)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 28, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 15, 2014)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 18, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 11, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 8, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 1, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 11, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 2, 2008)
- ADDITIONAL INVESTMENT RIGHT To Purchase $1,000,000 Principal Amount of 6% Convertible Debentures and Warrants Generex Biotechnology Corporation (Filed With SEC on January 20, 2006)
- ADDITIONAL INVESTMENT RIGHT To Purchase $1,000,000 Principal Amount of 6% Convertible Debentures and Warrants Generex Biotechnology Corporation (Filed With SEC on December 5, 2005)
- ADDITIONAL INVESTMENT RIGHT To Purchase $500,000 Principal Amount of 6% Convertible Debentures and Warrants Generex Biotechnology Corporation (Filed With SEC on October 31, 2005)
- ADDITIONAL INVESTMENT RIGHT To Purchase $500,000 Principal Amount of 6% Convertible Debentures and Warrants Generex Biotechnology Corporation (Filed With SEC on September 9, 2005)
